Australia Welcomes and Implements New E-Cigarette Reform Regulations

Regulations by 2FIRSTS.ai

Dec.04.2023

Australia Welcomes and Implements New E-Cigarette Reform Regulations

The Australian government welcomes new e-cigarette reform regulations to curb usage, including import bans and improved access for medical use.

According to a report by news-medical, the Australian government has welcomed and pledged to commit to new e-cigarette reform regulations. This move aims to suppress the use of e-cigarettes in Australia.

Starting from January 1, 2024, the government will enforce a ban on the importation of disposable e-cigarettes, while also improving the accessibility of medical e-cigarettes for individuals attempting to quit smoking.

Starting from March 1, 2024, further reform measures are expected to be implemented, including: ceasing the importation of personal e-cigarettes; banning the importation of non-therapeutic use e-cigarettes; requiring importers and manufacturers of therapeutic e-cigarettes to report to the Australian Government's Therapeutic Goods Administration about the conformity of their products to relevant product standards; and mandating importers to obtain permits and authorizations from the Australian Government's Office of Drug Control before importing the products.

References:

[1] Heart Foundation applauds new vaping reforms to curb e-cigarette use in Australia

Also Read:

[1] Increase in E-cigarette Sales Despite Australian Government's Reform Measures

[2] Australia Announces Ban on Disposable by 2024

#Legislation #Open system e-cigarettes #Disposable e-cigarettes #Australia #Regulation #Oceania #E-cigarette Regulation #E-cigarette #E-cigarettes and Tobacco

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Echo Guo: The Accumulating Risks Behind the Surge in Chinese Vape Exports to the U.S.

Chinese vape exports to the U.S. jumped from about 2.2 million kg in June to 14.8 million kg in October 2025, despite tougher enforcement, the Washington Examiner reported. 2Firsts finds the surge reflects delayed bulk shipments, not demand recovery. With U.S. inventory exceeding 160 million devices and distributors paying ~10% upfront, cash-flow stress has shifted to Chinese manufacturers, and discounted stock is spilling into other markets.

Dec.14 by Echo Duo

Philip Morris International Fails to Invalidate British American Tobacco Unit’s Vape Patent

The European Patent Office’s Board of Appeal upheld British American Tobacco’s Nicoventures Trading Ltd. vape patent, rejecting Philip Morris International’s objections. The board ruled that the patent’s use of predefined heater activation parameters not based on user puffs was novel and valid.

Nov.10

U.S. Lawmakers Seek to Empower HHS to Destroy Counterfeit Chinese Tobacco Products

Bipartisan members of the U.S. Congress have introduced the “Ensuring the Necessary Destruction of Illicit Chinese Tobacco Act” (END Act), seeking to amend the Federal Food, Drug, and Cosmetic Act to authorize the Department of Health and Human Services (HHS) to directly destroy adulterated, misbranded, or counterfeit imported tobacco products.Major tobacco companies, including Altria, along with several public health organizations, have announced their support for the bill.

Nov.11 by 2FIRSTS.ai

Interpreting FDA’s on! PLUS Authorization: What the Agency’s Press Release Reveals About Its Nicotine Pouch Review Model

The U.S. Food and Drug Administration has confirmed that six on! PLUS nicotine pouch products have received Marketing Granted Orders (MGO) through the PMTA pathway. The authorizations were completed under the agency’s nicotine pouch review pilot program in “record time,” with the FDA citing lower levels of harmful constituents while stressing that the decision applies only to the specified products and does not mean they are safe or FDA approved.